Advanced Bionics Defers Current Profits To Stimulate Neurostimulation
This article was originally published in The Gray Sheet
Executive Summary
Advanced Bionics is investing in implantable neurostimulators to extend beyond its initial product segment in cochlear implants. The Sylmar, California company is predicting the start of clinical trials on neurostimulators for urge incontinence and pain by the end of this year
You may also be interested in...
ANS Genesis Totally Implantable Spinal Cord Stimulator Gains FDA Approval
Advanced Neuromodulation Systems says it will launch its Genesis totally implantable pulse generator (IPG) spinal cord stimulation (SCS) system in January. FDA approval of the device was announced Nov. 21
Med-El, Advanced Bionics Launch Behind-the-Ear Speech Processors
Med-El is touting the extended battery life of its Combi 40+ cochlear implant system as a major competitive advantage following its recent U.S. launch of the product.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.